GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy.
Transl Lung Cancer Res
; 9(5): 2008-2015, 2020 Oct.
Article
em En
| MEDLINE
| ID: mdl-33209620
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Guideline
Idioma:
En
Revista:
Transl Lung Cancer Res
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
China